DCGI gives nod for restricted emergency use of Russian COVID-19 vaccine Sputnik V in India: Sources

The SEC on Monday deliberated upon the application of Dr Reddys Laboratories seeking emergency use authorisation for Sputnik V.

PTI | New Delhi | Updated: 13-04-2021 00:33 IST | Created: 13-04-2021 00:32 IST
DCGI gives nod for restricted emergency use of Russian COVID-19 vaccine Sputnik V in India: Sources
Representative Image Image Credit: ANI

India's drug regulator has granted permission for the restricted emergency use of Russian COVID-19 vaccine 'Sputnik V' with certain conditions, paving the way for a third vaccine to be available in the country, sources said on Monday.

The approval by the Drugs Controller General of India (DCGI) came after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Monday recommended granting approval to Sputnik V for restricted emergency use subject to certain regulatory conditions.

The DCGI had in January given the emergency use authorisation for two COVID-19 vaccines -- Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca manufactured by Serum Institute of India in Pune.

According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months. The SEC on Monday deliberated upon the application of Dr Reddy's Laboratories seeking emergency use authorisation for Sputnik V. The vaccine is indicated for active immunisation to prevent COVID-19 in individuals aged 18 years and above and is to be administered intramuscularly in two doses of 0.5 ml each with an interval of 21 days.

It has to be stored at -18 degrees Celsius.

According to recommendations by the SEC, the firm has been asked to submit revised factsheets to CDSCO after incorporating the latest safety and efficacy data and other suggestions made during the meeting, another source said.

Besides, the firm should submit the safety, efficacy and immunogenicity data from the ongoing clinical trials in India and Russia for review as and when available.

The firm also has to submit safety data, including the data on AEFI and AESI with due analysis every 15 days for the first two months and monthly thereafter till the completion of the ongoing clinical trial in the country, as per the recommendations.

The SEC had reviewed the application by Dr Reddy's in two meetings held on April 1 and February 24.

The health ministry earlier had said three more COVID-19 vaccines by Zydus Cadila, Biological E and Gennova are also in the pipeline and are in advanced clinical trials in India.

Global healthcare major Johnson and Johnson is in discussions with the Indian government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday.

In light of the SEC meeting held on April 1, Dr Reddy's on Monday presented the interim safety and immunogenicity data from phase 2/3 clinical trial, including GMT titres for virus neutralising antibodies, comparative phase 3 immunogenicity data generated in Indian and Russian studies and unblinded data of serious adverse events and RT-PCR positive cases among others.

In September last year, Dr Reddy's partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and for its distribution rights in India.

Sputnik V has demonstrated an efficacy rate of 91.6 per cent in the interim analysis of phase 3 clinical trial, which included data on 19,866 volunteers in Russia. PTI PLB SRY

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)



Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...


Latest News

LG visits GMC Jammu, reviews COVID management measures

Jammu and Kashmir Lt Governor Manoj Sinha on Sunday visited Government Medical College GMC hospital here and directed the management to operationalise the additional 100-bedded COVID ward at the earliest, an official spokesman said.Sinha vi...

Funeral of Kerala woman killed in Israel held at church in Idukki

The funeral of the Kerala woman, who died in Israel following a Palestinian rocket strike earlier this week, was held at Nithya Sahaya Matha Church in Keerithodu of Idukki district on Sunday. The mortal remains of Soumya Santhosh 30 were br...

Soccer-Liverpool's Jota out of final three games of the season

Liverpool forward Diogo Jota will miss their remaining fixtures after sustaining a foot injury in Thursdays 4-2 victory over Manchester United, manager Juergen Klopp said on Sunday. The injury rules the Portuguese out of Liverpools league c...

U.N. chief says Israel, Gaza fighting 'utterly appalling'

U.N. Secretary-General Antonio Guterres told the U.N. Security Council on Sunday that hostilities in Israel and Gaza were utterly appalling and called for an immediate end to fighting. Opening the 15-member councils first public meeting on ...

Give Feedback